Orbimed Advisors is a fund manager in New York with $17.32 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Industry
SEC CIK
Corporate docs
IRS number
133976876
SEC advisor number
801-61046
FINRA CRD number
118608
AUM ?
$18.21 bn
(as of 27 Mar 24)
Accounts
31
(as of 27 Mar 24)
Employees
112
(83 investment advisory or research)
Address
Orbimed Advisors
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY 10022
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY 10022
Phone
(212) 739-6400
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Orbimed Advisors LLC | $17.32 bn | |
Orbimed Asia Partners II, L.P. | $408.99 mm | Other Private Fund |
Orbimed Asia Partners III, L.P. | $1.21 bn | Other Private Fund |
Orbimed Asia Partners IV, L.P. | $931.06 mm | Other Private Fund |
Orbimed Asia Partners V, LP | $497.45 mm | Other Private Fund |
Orbimed Asia Partners, L.P. | $112.67 mm | Other Private Fund |
Orbimed Associates III, LP | $1.00 mm | Other Private Fund |
Orbimed Genesis Master Fund, L.P. | $370.84 mm | Hedge Fund |
Orbimed Genesis Fund, LTD. | ||
Orbimed Genesis Fund, L.P. | ||
Orbimed Global Healthcare Master Fund, L.P. | $542.31 mm | Hedge Fund |
Orbimed Global Healthcare Fund, L.P. | ||
Orbimed Global Healthcare Fund, LTD. | ||
Orbimed Global Healthcare Associates Fund, L.P. | ||
Orbimed Israel Partners II, L.P. | $370.33 mm | Other Private Fund |
Orbimed Israel Partners Limited Partnership | $148.97 mm | Other Private Fund |
Orbimed New Horizons Master Fund, L.P. | $195.14 mm | Hedge Fund |
Orbimed New Horizons Fund, LTD. | ||
Orbimed New Horizons Fund, L.P. | ||
Orbimed Partners Master Fund Limited | $1.08 bn | Hedge Fund |
Orbimed Partners, LTD. | ||
Orbimed Partners II, L.P. | ||
Orbimed Partners SPV, LTD. | $22.32 mm | Hedge Fund |
Orbimed Private Investments III, LP | $68.45 mm | Other Private Fund |
Orbimed Private Investments IV, LP | $158.06 mm | Other Private Fund |
Orbimed Private Investments IX, LP | $1.69 bn | Other Private Fund |
Orbimed Private Investments V, LP | $1.08 bn | Other Private Fund |
Orbimed Private Investments VI, LP | $1.77 bn | Other Private Fund |
Orbimed Private Investments VII, LP | $1.67 bn | Other Private Fund |
Orbimed Private Investments VIII, LP | $1.54 bn | Other Private Fund |
Orbimed Royalty & Credit Opportunities III, LP | $1.17 bn | Private Equity Fund |
Orbimed Royalty & Credit Opportunities IV, LP | $1.01 bn | Private Equity Fund |
Orbimed Royalty Opportunities II, LP | $314.55 mm | Hedge Fund |
Royalty Opportunities S.ar.l. | $73.87 mm | Hedge Fund |
Royalty Opportunities Feeder S.a. |
Latest ownership filings
4
NeuroPace Inc
18 Apr 24
4
NeuroPace Inc
15 Apr 24
SC 13D/A
Passage BIO, Inc.
12 Apr 24
3/A
Traws Pharma, Inc.
12 Apr 24
4
Kinnate Biopharma Inc.
5 Apr 24
SC 13D/A
Enliven Therapeutics, Inc.
4 Apr 24
3
Traws Pharma, Inc.
3 Apr 24
SC 13D
Q32 Bio Inc.
28 Mar 24
3
Q32 Bio Inc.
27 Mar 24
SC 13D/A
Compass Therapeutics, Inc.
22 Mar 24
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Apr 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 14.06 | 2,623 | 36.88 k | 3,501,975 |
17 Apr 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 14.15 | 300 | 4.25 k | 3,504,598 |
16 Apr 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 14.01 | 14,069 | 197.11 k | 3,504,898 |
12 Apr 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 14.42 | 23,101 | 333.12 k | 3,518,967 |
11 Apr 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 14.49 | 461,899 | 6.69 mm | 3,542,068 |
3 Apr 24 | Orbimed Advisors | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 450,000 | 0.00 | 0 |
3 Apr 24 | Orbimed Advisors | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 84,599 | 0.00 | 0 |
3 Apr 24 | Orbimed Advisors | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 1,368,338 | 0.00 | 0 |
3 Apr 24 | Orbimed Advisors | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 4,738,453 | 0.00 | 0 |
3 Apr 24 | Orbimed Advisors | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 1,368,339 | 0.00 | 0 |